held in DanCann Pharma A/S, CVR-no. 39 42 60 05 (“Company”) on Tuesday,...
pharma
Today, on 21 January 2025, an extraordinary general meeting was held in...
Post-pandemic, health and pharma have continued to be the focus of the union government. Sources say that...
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE...
ODI Pharma AB (“ODI Pharma”) hereby informs the termination of the agreement regarding...
COPENHAGEN, Denmark, 06 January 2025 – The Board of Directors of DanCann Pharma...
The Board of Directors hereby convenes an extraordinary general meeting of DanCann...
Today, the 30th of December 2024, ODI Pharma AB (publ) held its Annual...
Uppsala, Sweden, December 17, 2024. Results from Dicot Pharma’s recent clinical trial have...
LEXINGTON, Mass., Charlotte, N.C., United States:
Tanner Pharma, a global provider of...